Evaluation and Management of Pancolitis

Initial Diagnostic Evaluation

• The European Crohn’s and Colitis Organisation recommends flexible sigmoidoscopy as the preferred initial endoscopic procedure to confirm the diagnosis and assess severity of pancolitis, particularly looking for hemorrhagic mucosa with deep ulceration, mucosal detachment, and well-like ulceration 1, 2
• The American Gastroenterological Association suggests that full colonoscopy should be avoided in acute severe colitis, especially in patients on corticosteroids, due to perforation risk 1, 2
• Endoscopic assessment remains the gold standard for evaluating disease severity, according to the American College of Gastroenterology 3
• A complete blood count should be obtained to assess for anemia and leukocytosis, as recommended by the European Crohn’s and Colitis Organisation 2, 3
• Inflammatory markers (CRP or ESR) should be measured, noting that up to 15% of patients may not mount a CRP response despite active disease, according to the American College of Gastroenterology 3
• Serum electrolytes and liver function tests should be obtained, as suggested by the European Crohn’s and Colitis Organisation 2
• Serum albumin should be measured, as hypoalbuminemia (<2.5 g/dL) predicts severe disease and poor outcomes, according to the American College of Gastroenterology 3
• A stool sample for culture and C. difficile toxin assay should be obtained to exclude infectious colitis, as recommended by the European Crohn’s and Colitis Organisation 1, 2
• Fecal calprotectin levels >250 μg/g strongly correlate with active inflammation and ulceration, according to the American College of Gastroenterology 3

Severity Stratification

• Bloody diarrhea with high stool frequency (>6 bowel movements daily) is a clinical feature indicating severe disease, according to the American Gastroenterological Association 3
• Nocturnal symptoms, fever, weight loss, and tachycardia and hypotension requiring immediate resuscitation are also indicators of severe disease, as suggested by the European Crohn’s and Colitis Organisation 2, 3
• Absence of diarrhea may paradoxically signal progression to fulminant disease, according to the American College of Gastroenterology 3

Management Based on Disease Severity

• For mild to moderate pancolitis, the American College of Gastroenterology recommends mesalamine 2-4 g daily orally as the preferred initial treatment 5, 4
• For suboptimal response, escalate to high-dose mesalamine (>3 g/day) with rectal mesalamine, as suggested by the American Gastroenterological Association 4
• For moderate to severe pancolitis, oral prednisolone 40 mg daily is recommended for induction of remission, according to the European Crohn’s and Colitis Organisation 5, 4
• For severe/acute severe pancolitis, hospital admission with joint management by gastroenterologist and colorectal surgeon is required, as recommended by the American College of Gastroenterology 2, 4
• Intravenous corticosteroids (hydrocortisone 400 mg/day or methylprednisolone 60 mg/day) should be administered, according to the American Gastroenterological Association 4

Maintenance Therapy

• Lifelong maintenance therapy is generally recommended for pancolitis to reduce relapse risk and potentially colorectal cancer risk, as suggested by the American College of Gastroenterology 4
• Options include 5-ASA, thiopurines, anti-TNF agents, or vedolizumab depending on disease severity and prior response, according to the European Crohn’s and Colitis Organisation 4

Common Pitfalls

• Full colonoscopy should not be performed in acute severe colitis, as recommended by the American College of Gastroenterology 1, 2
• Surgical consultation should not be delayed in severe disease, according to the European Crohn’s and Colitis Organisation 2
• Infectious triggers should not be missed, and C. difficile and other pathogens should be excluded before escalating immunosuppression, as suggested by the American Gastroenterological Association 1, 2